Reinventing Clinical Development: Why it’s time for us to lead the AI‑enabled future
Session Chair
Chrissie is the Vice President and Head for Respiratory, Immunology and Inflammation Statistics at GSK. She leads a group of statisticians supporting the development of medicines in respiratory, hepatology, inflammation and fibrosis, neuroscience, and renal disease areas covering pre-clinical research through to post-approval activities. Chrissie also manages a group of statisticians based in India who support the R&D portfolio. Chrissie has worked in the Pharmaceutical Industry for 35 years and she has experience of developing and commercialising new medicines in a variety of disease areas across all phases of clinical development.
Chrissie is actively engaged in statistical societies, pharmaceutical trade associations and initiatives relating to the Pharmaceutical Industry. Chrissie leads the EFSPI Statistics Leaders Forum, and she is a member of the EFPIA Clinical Research Expert Group where she co-leads the Innovation in Clinical Trials team. Chrissie leads the EFPIA/EFSPI estimand implementation working group (ICH E9(R1)) and she is a Council member of the Royal Statistical Society.
In 2019 Chrissie was given honorary membership for her outstanding service to PSI, and she was selected for the Women in Data “Twenty in Data and Technology” award which showcases phenomenal women who encompass every level of seniority and data discipline, and who continue to make role models visible within their industry professions.
Chrissie is a Chartered Statistician of the Royal Statistical Society (RSS). Chrissie has an MSc in Applied Statistics and a BSc (Hons) in Statistics with Management Science Techniques.